Product Images Labetalol Hydrochloride

This is a product description for a medication called Labetalol Hydrochloride. It is a single dose vial that is intended for intravenous injection only. The injection has a strength of 5mg/mL and is available in a 20mL/4mL size. The medication is used to treat high blood pressure and must be stored at controlled room temperature to protect it from freezing or high temperatures. It is manufactured in India by a company called Caplin Steriles Limited and distributed by Baxter Healthcare Corporation in the USA.*

This is a description for a medication labeled NDC 36000-320-01. It is a 4 mL injection containing Labetalol Hydrochloride at a concentration of 20 mg/4 mL (5 mg/mL). The medication should be protected from freezing, stored at a controlled room temperature between 20° C and 25° C, and out of direct light. It's intended for intravenous injection only, and should only be used with a prescription (Rx Only). The carton should be retained until the medication is ready for use. The manufacturer is Baxter, and the lot number is 2232882.*

Labetalol Hydrochloride Injection is a sterile, aqueous solution that is used for intravenous injection only. Each 40 mL multi-dose vial contains 200 mg of labetalol hydrochloride USP, which is equivalent to 5 mg/mL. Necessary sodium hydroxide NF and citric acid anhydrous USP, 0.1 mg edetate disodium USP, and 45 mg anhydrous dextrose USP are added to adjust the pH. It also contains 0.8 mg methylparaben NF and 0.1 mg propylparaben NF as preservatives. The product must be protected from freezing and light and stored at controlled room temperature. Please refer to the package insert for the correct dosage. Manufactured by Gaplin Steriles Limited, Gummidipoondi-601 201, India, and distributed in the USA by Baxter Healthcare Corporation, Deerfield, IL 60015.*

This is a medication called Labetalol Hydrochloride, stored in a multi-dose vial with a dosage of 5mg per mL. It also contains anhydrous dextrose, edetate disodium, citric acid anhydrous, methylparaben, and propylparaben, which serve as preservatives. It is for intravenous injection only and should be kept in its carton until use. The text also provides instructions for storage and product details such as the expiration date and the manufacturer. Not available.*

This is a description of the dosage and ingredients in a Labetalol Multi-Dose Vial for intravenous use. The usual dosage is provided in the package insert and the vial contains 5mg of labetalol hydrochloride USP and 45mg of anhydrous dextrose USP per mL. Other ingredients include edetate disodium USP, citric acid injection USP, methylparaben NF, and propylparaben NF, among others. The solution is sterile and should be stored at 20-25°C. The vial is manufactured for Baxter Healthcare Corporation in Deerfield, IL. NDC 36000-322-01 20mL. Protect from freezing.*

This is a description of a medication contained in a multi-dose vial with NDC code 36000-322-02. The medication is Labetalol Hydrochloride Injection USP, with a concentration of 5mg/mL or 6mg/mL. It is intended for intravenous injection only and is available with a prescription. Usual dosage is indicated in the package insert. The solution consists of labetalol hydrochloride, anhydrous dextrose, edetate disodium, and methylparaben and propylparaben as preservatives. The solution should be stored at 20°-25°C, and protected from freezing and light. The solution is manufactured by Gaplin Steriles Limited in India under Code No: TN/Drugs/TNO0003457, and is manufactured for Baxter Healthcare Corporation in Deerfield, IL, USA.*